can retatrutide cause diarrhea and Diarrhoea: Evidence, Frequency, and Safe Management – Bolt Pharmacy Unapproved weight loss drug retatrutide

But because the body processes the pill differently than the shot, people who found the injections intolerable may have a different experience with the pill

starts to impact reliability and yield

The trial was sponsored by Eli Lilly, which produces orforglipron and also makes the injectable GLP-1 drug tirzepatide under the brand names Mounjaro for type 2 diabetes and Zepbound for chronic weight loss

These drugs also appear to have major pleiotropic effects in CV risk reduction, (STEP trials , SELECT trial, STEP HFpEF, SCRIBE, SUMMIT, SURMOUNT-MMO (completion 2027)) reversal of metabolic dysfunctionassociated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (SYNERGY NASH MASH), and non-progression if not reversal of chronic kidney disease (CKD) (FLOW trial)

Fortunately, many of these effects are temporary and tend to improve as the body adjusts to treatment